Combined oral contraceptives (OC) are known to increase the risk of venous
thromboembolism. The aim of this randomized, cycle-controlled, cross-over study in 28 …

The use of oral contraceptives (OC) causes disturbances of the procoagulant, anticoagulant
and fibrinolytic pathways of blood coagulation which may contribute to the increased risk of …

An increased risk of venous thrombosis has been demonstrated in women receiving oral
contraceptives (OCs). This risk has been primarily associated with the oestrogen content, but …

In some studies third-generation oral contraceptives have been reported to be associated
with a higher risk of venous thromboembolism than are second-generation oral …

Abstract In October 1995 the Committee on Safety of Medicines advised UK doctors and
pharmacists that oral contraceptives containing desogestrel and gestodene were associated …

CONTEXT: Previous studies have reported that users of the “third-generation” oral
contraceptives (OCs) containing the progestins gestodene and desogestrel have about …

Research on the relationship between venous thromboembolism and the progestagen
content of combined oral contraceptives has pointed to an increase in risk associated with …

For many years, it has been well documented that combined hormonal contraceptives
increase the risk of venous thromboembolism (VTE). The third-generation pill use …

Background Two recent studies, a cohort study from Denmark, and a case-control study from
The Netherlands, have reported increased risks of venous thromboembolism (VTE) among …

To assess the influence of oral contraceptives (OC) on the risk for venous thromboembolism
(VTE) in young women, a 5-year case-control study including all women 15–44 years old …